The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(S)-(3-((7-(benzylamino)-3-isopropylpyrazolo[1,5-a]pyrimidin-5-ylamino)methyl)pyrrolidin-3-yl)methanol ID: ALA4553241
PubChem CID: 155555568
Max Phase: Preclinical
Molecular Formula: C22H30N6O
Molecular Weight: 394.52
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: CC(C)c1cnn2c(NCc3ccccc3)cc(NC[C@]3(CO)CCNC3)nc12
Standard InChI: InChI=1S/C22H30N6O/c1-16(2)18-12-26-28-20(24-11-17-6-4-3-5-7-17)10-19(27-21(18)28)25-14-22(15-29)8-9-23-13-22/h3-7,10,12,16,23-24,29H,8-9,11,13-15H2,1-2H3,(H,25,27)/t22-/m0/s1
Standard InChI Key: AUZGEDPWRMYCLE-QFIPXVFZSA-N
Molfile:
RDKit 2D
29 32 0 0 0 0 0 0 0 0999 V2000
22.6575 -7.5611 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.3706 -7.1546 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.0812 -7.5652 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
24.7942 -7.1587 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.5016 -7.5723 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
25.5087 -5.9306 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.7916 -6.3394 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.2192 -6.3476 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
26.2127 -7.1686 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.9918 -7.4272 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.4773 -6.7659 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.0022 -6.1013 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
25.5139 -5.1093 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
24.8046 -4.6962 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.8098 -3.8749 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.5239 -3.4712 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.5294 -2.6507 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.8197 -2.2368 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.1029 -2.6453 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.1009 -3.4645 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.9838 -8.2462 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.2680 -8.6520 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.6916 -8.6659 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.9092 -7.2321 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.3606 -7.8419 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.7672 -8.5550 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
22.5711 -8.3832 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.6502 -6.7398 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.9348 -6.3375 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 1
2 3 1 0
3 4 1 0
4 5 2 0
4 7 1 0
5 9 1 0
8 6 1 0
6 7 2 0
8 9 1 0
9 10 2 0
10 11 1 0
11 12 2 0
12 8 1 0
6 13 1 0
13 14 1 0
14 15 1 0
15 16 2 0
16 17 1 0
17 18 2 0
18 19 1 0
19 20 2 0
20 15 1 0
10 21 1 0
21 22 1 0
21 23 1 0
1 24 1 0
24 25 1 0
25 26 1 0
26 27 1 0
27 1 1 0
1 28 1 0
28 29 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 394.52Molecular Weight (Monoisotopic): 394.2481AlogP: 2.85#Rotatable Bonds: 8Polar Surface Area: 86.51Molecular Species: BASEHBA: 7HBD: 4#RO5 Violations: ┄HBA (Lipinski): 7HBD (Lipinski): 4#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: 10.46CX LogP: 2.16CX LogD: -0.68Aromatic Rings: 3Heavy Atoms: 29QED Weighted: 0.47Np Likeness Score: -0.74
References 1. Teng Y, Lu K, Zhang Q, Zhao L, Huang Y, Ingarra AM, Galons H, Li T, Cui S, Yu P, Oumata N.. (2019) Recent advances in the development of cyclin-dependent kinase 7 inhibitors., 183 [PMID:31514062 ] [10.1016/j.ejmech.2019.111641 ]